Three currently circulating omicron subvariants of SARS-CoV-2 – including two that currently make up almost 50% of reported COVID-19 infections in the U.S. – are better at evading vaccine- and infection-generated neutralizing antibodies than earlier versions of omicron, new research suggests.
news.osu.eduSubmitted by memorialmonorail t3_z22fjv in science
Viewing a single comment thread. View all comments